Hyperactivation of the RAS signaling pathway in myelodysplastic syndrome with AML1/RUNX1 point mutations.
about
Development of hairy cell leukemia in familial platelet disorder with predisposition to acute myeloid leukemia.Runx1 regulation of Pu.1 corepressor/coactivator exchange identifies specific molecular targets for leukemia differentiation therapy.NF1 inactivation in adult acute myelogenous leukemiaAssessing karyotype precision by microarray-based comparative genomic hybridization in the myelodysplastic/myeloproliferative syndromesRUNX1 regulates corepressor interactions of PU.1.Molecular pathophysiology of myelodysplastic syndromes.Genetics of therapy-related myelodysplasia and acute myeloid leukemia.Oncogene-induced senescence: an essential role for Runx.Genome wide molecular analysis of minimally differentiated acute myeloid leukemia.Update on genetic and molecular markers associated with myelodysplastic syndromes.Unraveling the molecular pathophysiology of myelodysplastic syndromes.Suppression of farnesyltransferase activity in acute myeloid leukemia and myelodysplastic syndrome: current understanding and recommended use of tipifarnib.RUNX1 meets MLL: epigenetic regulation of hematopoiesis by two leukemia genes.-7/7q- syndrome in myeloid-lineage hematopoietic malignancies: attempts to understand this complex disease entity.Role of RUNX1 in hematological malignancies.RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells.Runx2 disruption promotes immortalization and confers resistance to oncogene-induced senescence in primary murine fibroblasts.AML1/RUNX1 gene point mutations in childhood myeloid malignancies.A novel pedigree with heterozygous germline RUNX1 mutation causing familial MDS-related AML: can these families serve as a multistep model for leukemic transformation?
P2860
Q33409963-027E9220-683D-4C1A-A524-DE31A2019D03Q33652165-E61DE793-9ED5-4DC9-A817-0D319FAAD084Q34065032-8BA7305A-234C-49C1-BFD7-620A0DE80F79Q34400180-51C2CA64-61D4-4DFA-84FC-521B50D2E73FQ35067608-A82C385C-EC4E-4500-9F23-91FC38BDFD2AQ36445968-61BF599C-2FA4-493B-8FA5-F6ACD7A7D96FQ37058777-AAF157AE-F342-4DA8-B5ED-46D50F257F5AQ37234252-BAC2E597-75E8-4BA0-80FB-89AD8CC535EBQ37406787-2EC541EF-4F8E-4941-966F-02E08C706AF9Q37407161-865AF5EE-E9D3-4944-BA3F-E80E74946C12Q37671806-1B33C716-E29D-4B26-98CF-8C39C73B6F81Q37733593-5C251F91-D1CC-42F0-B6E2-F19B91704EA7Q38118553-60372778-19B7-4414-A7A8-F9F4F5B1A13FQ38226741-FEEDF408-6D7A-4B93-8612-BD883F6FB65AQ39127024-AD860794-82E9-4041-94BE-100981BC330CQ42709502-BA7CFC67-DEA3-498B-B03E-3CBA985B3B0AQ42819809-7734B6AD-2649-44C3-A821-488792BE4499Q46215182-1803EEF2-A2BD-4A6F-B7D8-0A46BB9B35EEQ47959794-D9CC09FD-1FD9-4E7D-8FD9-F60EAAEED88C
P2860
Hyperactivation of the RAS signaling pathway in myelodysplastic syndrome with AML1/RUNX1 point mutations.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Hyperactivation of the RAS sig ...... th AML1/RUNX1 point mutations.
@en
type
label
Hyperactivation of the RAS sig ...... th AML1/RUNX1 point mutations.
@en
prefLabel
Hyperactivation of the RAS sig ...... th AML1/RUNX1 point mutations.
@en
P2093
P2860
P356
P1433
P1476
Hyperactivation of the RAS sig ...... th AML1/RUNX1 point mutations.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.LEU.2404136
P577
2006-04-01T00:00:00Z
P5875
P6179
1035975191